セグメントの状況 データブック | IR資料室 | 株主・投資家情報 | 株式会社メディパルホールディングス

. ^{セグメン の状況 セグメン 間取引を含む} Segment Overview (Including Intersegment Sales and Transfers)

売上高 _{Net Sales}

万 ％ Millions of Yen ^％

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition 金額

Amount ^{1,018,842 983,390 1,038,166 1,026,949}

前 比

YoY ^{3.6 ᇞ 3.5 5.6 ᇞ 1.1}

金額

Amount ^{403,888 401,341 425,492 475,080}

前 比

YoY ^{3.7 ᇞ 0.6 6.0 11.7}

金額

Amount ^{21,449 21,606 23,447 29,872}

前 比

YoY ^{0.0 0.7 8.5 27.4}

ᇞ ^{1,316 △0.1%} ᇞ ^{1,414 △0.1%} ᇞ ^{1,381 △0.1%} ᇞ ^{1,496 △0.1%} ᇞ ^{1,535 △0.1%} ᇞ ^{3,132 △0.1%}

金額

Amount ^{1,442,863 1,404,923 1,485,725 1,530,406}

前 比

YoY ^{3.6 ᇞ 2.6 5.8 3.0}

売上総利益 Gross Profit

^{万 ％} Millions of Yen ^％

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition 金額

Amount ^{67,449 65,241 66,639 68,942 68,150 139,567}

売 比

Margin ^※1 ^{6.6 6.6 6.4 6.7 6.6 6.7}

金額

Amount ^{31,591 30,910 33,310 36,433 38,487 71,348}

売 比

Margin ^{7.8 7.7 7.8 7.7 7.8 7.7}

金額

Amount ^{3,309 3,339 3,587 4,258 4,441 8,431}

売 比

Margin ^{15.4 15.5 15.3 14.3 14.1 14.1}

ᇞ ^{85 △0.1%} ᇞ ^{90 △0.1%} ᇞ ^{100 △0.1%} ᇞ ^{118 △0.1%} ᇞ ^{26 △0.1%} ᇞ ^{327 △0.1%}

金額

Amount ^{102,265 99,401 103,437 109,515 111,052 219,019}

売 比

Margin ^{7.1 7.1 7.0 7.2 7.1 7.1}

販管費 Selling, General and Administrative Expenses

^{万 ％} Millions of Yen ^％

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition 金額

Amount ^{59,500 58,457 57,631 59,803 61,866 120,897}

売 比

Ratio to sales ※2 ^{5.8 5.9 5.6 5.8 6.0 5.8}

金額

Amount ^{24,223 23,726 24,684 25,738 26,051 52,233}

売 比

Ratio to sales ^{6.0 5.9 5.8 5.4 5.3 5.7}

金額

Amount ^{3,113 3,094 3,116 3,620 3,661 7,280}

売 比

Ratio to sales ^{14.5 14.3 13.3 12.1 11.6 12.2}

ᇞ ^{470 △0.5%} ᇞ ^{423 △0.5%} ᇞ ^{437 △0.5%} ᇞ ^{482 △0.5%} ᇞ ^{187 △0.2%} ᇞ ^{1,042 △0.6%}

金額

Amount ^{86,366 84,854 84,995 88,679 91,392 179,369}

売 比

Ratio to sales ^{6.0 6.0 5.7 5.8 5.9 5.9}

31,546 59,762 2.0%

16/9 17/9 17/3

事業

AGRO & FOOD

Business

5.6%

1.5% 1.5% 1.6% 2.0% 2.0%

4.2% 922,095 30.1% 2,085,175 68.0%

31.0% 494,838 31.7% 67.1% 1,035,400 66.4%

100.0%

13/9 14/9 15/9

15/9

64.4% 消去又 全社

Eliminations and Corporate

合 計

Total

Ｐ_ALTAC事業

PALTAC Business

事業

MEDICEO Business

^{70.6% 70.0% 69.9%}

28.6%

1.4% 100.0%

100.0%

合 計

Total

^{100.0% 100.0%}

67.8% 67.4% 67.7%

事業

MEDICEO Business

3.7% 4.1% 4.0%

ＰA TAC事業

PALTAC Business

100.0% 100.0% 100.0%

事業

AGRO & FOOD

Business

4.3% 3.8%

消去又 全社 Eliminations and Corporate

3.5%

34.7% 5.6% 32.6%

事業

AGRO & FOOD

Business

3.2% 3.4% 3.9% 4.0%

ＰA TAC事業

PALTAC Business

^{30.9% 31.1% 33.3%}

事業

MEDICEO Business

^{66.0% 65.6% 62.9%}

13/9

28.0% 28.0% 1.2% 29.1%

0.8%

100.0% 100.0% 100.0% 100.0%

28.0% 28.6%

100.0%

1,560,249 2.0% 3,063,900

32.2%

14/9 16/9 17/9 17/3

61.4% _ᇞ1.1%

100.0% 100.0%

100.0% 3.1% 100.0%

1.2% 4.1%

63.7%

13/9 14/9 15/9 16/9

29.0% 29.0% 28.5%

17/9 17/3

68.9% 68.9% 3.4% 67.4%

消去又 全社 Eliminations and Corporate

合 計

_Total

100.0%

3.6% 3.6%

注1. 売 比=売 総利益 ン 間 部売 高又 振 高 含 売 高 2. 販管費 売 比＝販管費 ン 間 部売 高又 振 高 含 売 高

Notes: 1. Margin: segment gross margin; the ratio of segment gross profit to total segment sales including intersegment sales and transfers.

2. Ratio to sales: the ratio of segment selling general and administrative expenses to total segment sales including intersegment sales and transfers.

営業利益 Operating Profit

^{万 ％} Millions of Yen ^％

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition 金額

Amount ^{7,948 6,784 9,007 9,139 6,284 18,670}

売 比

Margin ^※1 ^{0.8 0.7 0.9 0.9 0.6 0.9}

金額

Amount ^{7,368 7,183 8,626 10,694 12,436 19,114}

売 比

Margin ^{1.8 1.8 2.0 2.3 2.5 2.1}

金額

Amount ^{196 245 470 638 779 1,150}

売 比

Margin ^{0.9 1.1 2.0 2.1 2.5 1.9}

384 2.4% 333 2.3% 336 1.8% 363 1.7% 160 0.8% 714 1.8%

金額

Amount ^{15,898 14,547 18,441 20,836 19,660 39,650}

売 比

Margin ^{1.1 1.0 1.2 1.4 1.3 1.3}

経常利益 Ordinary Profit

^{万 ％} Millions of Yen ^％

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition 金額

Amount ^11,271

売 比

Margin ^{※ 1.1}

金額

Amount ^{－ 13,645}

売 比

Margin ^2.8

金額

Amount ⁸⁸¹

売 比

Margin ^2.8

4 0.0%

金額

Amount ^25,802

売 比

Margin ^1.7

親会社株主 帰属す 四半期 当期 純利益 Profit Attributable To Owners Of Parent

^{万 ％} Millions of Yen ^％

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition 金額

Amount ^10,911

売 比

Ratio to sales ^※3 ^1.1

金額

Amount ^4,679

売 比

Ratio to sales ^0.9

金額

Amount ⁵⁴⁷

売 比

Ratio to sales ^1.7

3 0.0%

金額

Amount ^16,141

売 比

Ratio to sales ^1.0

22.1% 2.9%

1.2% 1.7% 2.6% 3.1%

17/9 17/3

事業

AGRO & FOOD

Business

4.0%

13/9 14/9 15/9 16/9

48.8%

100.0% 100.0%

43.9%

100.0%

48.2%

32.0% _ᇞ31.2% 47.1%

ＰA TAC事業

PALTAC Business

^{46.4% 49.4% 46.8% 51.3% 63.2% 16.3%}

事業

MEDICEO Business

^{50.0% 46.6%}

100.0% _ᇞ5.6% 100.0%

消去又 全社 Eliminations and Corporate

合 計

_Total

100.0%

43.7%

13/9 14/9 15/9 16/9

－

－ _52.9%

17/9 17/3

事業

MEDICEO Business

－ －

事業

AGRO & FOOD

Business

－ － －

－ － －

－ _3.4%

－ －

ＰA TAC事業

PALTAC Business

^{－ － －}

－ －

消去又 全社 Eliminations and Corporate

合 計

_Total

－ － － － _100.0% － －

13/9 14/9 15/9 16/9 17/9 17/3

－

ＰA TAC事業

PALTAC Business

^{－ － － － 29.0% －}

事業

MEDICEO Business

^{－ － － － 67.6% －}

－ _100.0%

－

事業

AGRO & FOOD

Business

－ － － －

－ －

－

消去又 全社 Eliminations and Corporate

合 計

_Total

^{－ － －}

3.4% ^－

Notes: 1. Margin: segment operating profit margin; the ratio of segment operating profit to total segment sales including intersegment sales and transfers. 2. Margin: segment ordinary profit margin; the ratio of segment ordinary profit to total segment sales including intersegment sales and transfers. 3. Ratio to sales: segment profit attributable to owners of parent ratio; the ratio of segment profit attributable to owners of parent to total segment sales

including intersegment sales and transfers.

注 営業利益 売 比＝営業利益 ン 間 部売 高又 振 高 含 売 高 経常利益 売 比＝経常利益 ン 間 部売 高又 振 高 含 売 高

親会社株主 帰属 四半期当期純利益 売 比＝親会社株主 帰属 四半期当期純利益 ン 間 部売 高又 振 高 含 売 高

Data Book 2018 第2四半期

. ^{セグメン 別売上高の状況} Net Sales by Segment

商品別売上高 By Product Type

万 ％ Millions of Yen ％ 前 比

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition

事業

MEDICEO Business

^{1,018,842 100.0% 983,390 100.0% 1,038,166 100.0% 1,026,949 100.0% 1,035,400 100.0% 0.8% 2,085,175 100.0%}

医療用医薬品 Prescription pharmaceuticals

医療機器 Medical equipment

臨床検査試薬 Clinical diagnostics

そ Others

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition

ＰＡ Ａ 事業

PALTAC Business

^{403,888 100.0% 401,341 100.0% 425,492 100.0% 475,080 100.0% 494,838 100.0% 4.2% 922,095 100.0%}

粧品日用品 Cosmetics and daily necessities

一般用医薬品 OTC pharmaceuticals

そ Others

事業

AGRO & FOOD Business

^{21,449 100.0% 21,606 100.0% 23,447 100.0% 29,872 100.0% 31,546 100.0% 5.6% 59,762 100.0%}

消去又 全社

Eliminations and Corporate

^{ᇞ 1,316 ᇞ 1,414 ᇞ 1,381 ᇞ 1,496 ᇞ 1,535 ᇞ 3,132}

合 計 _Total

1,442,863 1,404,923 1,485,725 1,530,406 1,560,249 2.0% 3,063,900

13/9 14/9 15/9 16/9 17/9 17/3

922,853 90.6% 890,922 90.6% 940,812 90.6% 90.0%

4.1% 136,005 6.5% 65,501 6.4% 68,163

0.5% 1,873,833 89.9% 927,815 90.3% 932,395

6.5% 67,166 6.5% 6.6%

66,805 6.6%

0.7% 6,645 21,552 2.1%

63,861

2.3%

1.0% 11,047 1.1% 10.3% 26,027

2.3% 0.7% 49,308 2.4%

7,631

21,961

332,666

13/9 14/9

23,794 2.2% 22,790 2.2% 23,619

333,010 82.5%

17/9

4.3% 776,364 17/3

15/9 16/9

0.7% 7,398 0.7% 10,012 1.2%

84.2%

64,680 16.0% 61,641 15.4% 64,784 15.2% 67,893 14.3% 14.4%

82.9% 354,321 83.3% 401,001 84.4% 418,123 84.5%

70,299 14.2% 3.5% 132,589

1.3% 3.7%

注16/3 会計方針 変更等 行 たこ 伴い 計方法 15/9 変更し 14/9 数値 し 遡 適用し数値 修正し

Note: Due to changes in accounting policies from the fiscal year ended March 31, 2016, the calculation method has changed from the interim period ended September 30, 2015. Figures for the interim period ended September 30, 2014 have been restated to reflect the new calculation method.

1.5% 6,184 1.3% 6,415

6,197 1.5% 7,034 1.7% 6,386 13,141 1.4%

販路別売上高 By Customer Type

万 ％ Millions of Yen ％ 前 比

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition

事業

MEDICEO Business

^{1,018,842 100.0% 983,390 100.0% 1,038,166 100.0% 1,026,949 100.0% 1,035,400 100.0% 0.8% 2,085,175 100.0%}

大病院 床以 Large hospitals (200 or more beds)

中小病院 ～ 床 Small, medium-sized hospitals (20 to 199 beds)

診療所 床以 Clinics (19 or fewer beds)

調剤薬局 Dispensing pharmacies

そ Others

前 比 構成比

Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition

ＰＡ Ａ 事業

PALTAC Business

^{403,888 100.0% 401,341 100.0% 425,492 100.0% 475,080 100.0% 494,838 100.0% 4.2% 922,095 100.0%}

Drugstores

コン ニ ン Convenience stores

ンタ Home centers

Supermarkets

ウン Discount stores

そ Others

Notes:

事業

AGRO & FOOD Business

^{21,449 100.0% 21,606 100.0% 23,447 100.0% 29,872 100.0% 31,546 100.0% 5.6% 59,762 100.0%}

消去又 全社

Eliminations and Corporate

^{ᇞ 1,316 ᇞ 1,414 ᇞ 1,381 ᇞ 1,496 ᇞ 1,535 ᇞ 3,132}

合 計 Total

1,442,863 1,404,923 1,485,725 1,530,406 1,560,249 2.0% 3,063,900 48,215 10.1%

140,768 13.7%

500,203 48.7%

60,417 5.9%

注

53,161 5.8%

35,365 5.4% 24,311 5.7% 26,844 5.7% 29,760 6.0% 10.9%

3.8% ᇞ^{10.8% 99,552 10.8%}

3.3% 15,915 3.7% 17,171 3.6% 19,898 4.0% 15.9% 18,671 4.6% 13,314

17,658 4.4% 21,638

49,971 12.5% 52,809 12.4% 53,924 11.4% 48,078 9.7% 54,542 13.5%

11.0% 49,797 10.1% 3.3% 88,846 9.6%

7.5%

45,550 11.3% 43,906 10.9% 46,551

30,019 7.1% 34,439 7.2% 35,800 7.2% 4.0% 69,082 576,085 62.5%

29,933 7.4% 31,762 7.9%

60.0% 255,885 60.1% 294,484 62.0% 311,502 63.0% 5.8% 237,532 58.8% 240,748

5.6% 57,318 5.9%

13/9 14/9 15/9

5.8% 64,526 6.2% 6.8% 123,361

57,482

17/9 17/3

59,991 5.8%

16/9 48.3%

0.5%

141,468 13.7% 295,238 14.2%

484,002 47.5% 474,524

141,709 146,297

512,581 49.4% 501,549 48.5% 0.3% 1,004,763 48.2%

14.4% 156,304 15.3%

81,128 8.0% 77,717 7.9%

23.2% 24.6%

232,120 23.6% 240,920

72,776 7.0%

1.2% 514,675 24.7%

ᇞ^1.0% 17/3

7.0% 147,136

14.1% 7.5% 78,375 239,924

17/9

23.6%

13/9 14/9 15/9

255,079 16/9

252,046 24.5%

73,513 7.2%

ウン そ 分離独立し 載し

会計方針 変更等 行 たこ 伴い 計方法 変更し 数値 し 遡 適用し数値 修正し

1. From the fiscal year ended March 31, 2013, "Discount stores" is presented separately from "Others".

2. Due to changes in accounting policies from the fiscal year ended March 31, 2016, the calculation method has changed from the interim period ended September 30, 2015. Figures for the interim period ended September 30, 2014 have been restated to reflect the new calculation method.

Data Book 2018 第2四半期

. ^{セグメン 別売上高の状況} Net Sales by Segment

地域別売上高 _{By Region}

万 ％ Millions of Yen ％

前 比

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition

事業

MEDICEO Business

^{1,018,842 100.0% 983,390 100.0% 1,038,166 100.0% 1,026,949 100.0% 1,035,400 100.0% 0.8% 2,085,175 100.0%}

海道 Hokkaido 東 Tohoku

関東 Kita-Kanto 首都圏 Greater Tokyo 甲信越 Koshinetsu 東海 Tokai 陸 Hokuriku 近畿 Kinki 中国 Chugoku 四国 Shikoku

九州沖縄

Kyushu & Okinawa

前 比

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

構成比 Composition

Change from 16/9

構成比 Composition

ＰＡ Ａ 事業

PALTAC Business

^{403,888 100.0% 401,341 100.0% 425,492 100.0% 475,080 100.0% 494,838 100.0% 4.2% 922,095 100.0%}

海道東

Hokkaido & Tohoku 関東 Kanto 甲信越 Koshinetsu

東海 陸

Tokai & Hokuriku 近畿 Kinki

中国四国

Chugoku & Shikoku

九州沖縄

Kyushu & Okinawa

事業

AGRO & FOOD Business

^{21,449 100.0% 21,606 100.0% 23,447 100.0% 29,872 100.0% 31,546 100.0% 5.6% 59,762 100.0%}

消去又 全社

Eliminations and Corporate

^{ᇞ 1,316 ᇞ 1,414 ᇞ 1,381 ᇞ 1,496 ᇞ 1,535 ᇞ 3,132}

合 計 _Total

1,442,863 1,404,923 1,485,725 1,530,406 1,560,249 2.0% 3,063,900

7.8% 23.9% 1.0% 498,294

19.9% 14.9%

1.6% 14,205 1.5%

101,868 9.9%

16/9

9.9%

42,569 10.5%

169,596 35.7% 16,116 1.6% 244,931 23.9% 80,854 7.9%

7.3% 35,586 7.2%

42,554 10.6%

5.5% 65,984 7.2%

33,737 7.1%

44,914 10.6% 49,686 10.4% 53,254 10.8% 7.2% 97,661 10.6%

32,033 7.9% 30,757 7.7% 31,259

89,393 21.0% 94,423 19.9% 99,013 20.0% 4.9% 183,457 137,334 67,139 15.8% 71,202 15.0% 73,286 14.8% 2.9%

87,081 21.6% 83,019 20.7% 16.1% 61,904 15.3% 64,705

5,963 1.5% 6,438 1.5% 7,422 1.6% 7,544 1.5%

5,904 1.5%

33.9% 175,746 35.5% 3.6% 327,117 35.5%

10.4% 135,830 33.6% 133,824 33.3% 144,415

41,931 9.9% 49,012 10.3% 50,406 10.2% 2.8% 96,334

38,566 9.6% 40,517 10.1% 104,299 10.2% 99,986

13/9 14/9 17/9 17/3

10.2% 102,479 9.9% 0.6%

－

105,670 205,821

10.2% 83,246 8.2% 78,866 8.0%

15/9

－ － － － － － － _{3 0.0%} －

1.5% 242,299

1.6% 16,030 1.5% 16,123

246,809 23.8% 247,307

23.8% 234,358 23.8% 23.9%

66,943 6.6%

32,063 1.5% 0.0%

7.8% 0.1%

8.0% 80,897

82,774 162,875

2.7% 27,983 2.7%

35.0%

2.5% 143,940 6.9% 15,994 1.6% 15,708

65,606 6.7% 70,298 6.8% 69,519 6.8% 71,252 6.9%

35.0%

130,574

28,707 2.8% 28,009 2.8% 29,111 2.8% 27,924 2.7% _ᇞ0.2% 56,479

65,076 6.4% 62,630 6.3%

348,686 34.2% 338,271 34.4%

6.4% 65,730 6.3% 64,249 6.3% 68,226 6.6% 6.2%

358,042 34.5% 359,017 359,933 34.8% 0.3% 730,208

50,825 4.9% 49,820 4.9% 48,885 4.7%

51,262 5.0% 47,721 4.9%

1.2% _ᇞ1.8% 25,142 1.2% 12,588 1.2%

17/3

ᇞ^{1.9% 99,774 4.8%}

13/9 14/9 15/9 16/9 17/9

12,326 1.2% 12,231 1.2% 12,872 1.2% 12,366

メ ィセ 事業　メ 別売上高 MEDICEO Business, by Manufacturer

万 Millions of Yen

金額

Amount

構成比

Composition^％

1 武田薬品工業 131,308 12.7%

2 44,952 4.3%

3 製薬 44,728 4.3%

4 中外製薬 41,331 4.0%

5 大塚製薬 38,614 3.7%

6 第一 共 30,157 2.9%

7 薬品 29,535 2.9%

8 ン 26,867 2.6%

9 ^日 26,641 2.6%

10 小野薬品工業 24,752 2.4%

11 24,693 2.4%

12 田辺 菱製薬 23,020 2.2%

13 22,995 2.2%

14 19,036 1.8%

15 18,285 1.8%

16 ^そ 488,478 47.2%

医療用医薬品等卸売事業 計 _Total 1,035,400 100.0%

メ ィセ 事業　品目別売上高　 MEDICEO Business, by Brand

万 Millions of Yen

17/9

売 高 _Sales

1 AZILVA ^{武田薬品工業} 11,760

2 ^{ュ ン} Leuplin ^{武田薬品工業} 11,503

3 ^チン Avastin ^中外製薬 10,614

4 ^タ TAKECAB ^{武田薬品工業} 10,268

5 Opdivo ^{小野薬品工業} 9,053

6 ^ン Enbrel ^{武田薬品工業} 9,028

7 Xarelto ^薬品 8,873

8 Lyrica 7,326

9 Lotriga ^{武田薬品工業} 6,919

10 MOHRUS ^久光製薬 6,881

11 EYLEA ^参天製薬 6,589

12 Samsca ^大塚製薬 5,371

13 Vectibix ^{武田薬品工業} 5,231

14 ^ュ HUMIRA 5,186

15 FORTEO ^日 5,131

16 ^ュ Eliquis 5,024

17 ^{ン タ} Cymbalta ^日 4,976

18 ABILIFY ^大塚製薬 4,736

19 E Keppra ^大塚製薬 4,688

20 CRESTOR 4,632

Takeda Pharmaceutical Company Limited

Eli Lilly Japan K.K.

Others

Eli Lilly Japan K.K.

Manufacturer

17/9

Takeda Pharmaceutical Company Limited

Pfizer Japan Inc.

Astellas Pharma Inc.

GlaxoSmithKline K.K.

Eisai Co., Ltd.

Mitsubishi Tanabe Pharma Corporation

Merck Sharp & Dohme Corp.

AstraZeneca Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd.

DAIICHI SANKYO COMPANY, LIMITED

ONO PHARMACEUTICAL CO., LTD.

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

Eisai Co., Ltd.

Pfizer Japan Inc.

Bayer Yakuhin, Ltd.

Novartis Pharma K.K.

品 _{Brand Name} Manufacturer

Takeda Pharmaceutical Company Limited

Chugai Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd.

Pfizer Japan Inc.

Takeda Pharmaceutical Company Limited

Hisamitsu Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co.,Ltd

Takeda Pharmaceutical Company Limited

ONO PHARMACEUTICAL CO., LTD.

Bayer Yakuhin, Ltd.

Eli Lilly Japan K.K.

AstraZeneca Co., Ltd.

注 漢方製剤 し 品目別売 高 た 載し 売 高 合計 , 万 あ

Note: Sales of Kampo medicines (TSUMURA & CO.), which are not included in the above table showing sales by brand, totaled ¥12,112 million.

Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd.

Data Book 2018 第2四半期